Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPO | P05164 | 2/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | KDM5A | P29375 | 1/20 | 0.64 |
| ▸ | BLM | P54132 | 1/20 | 0.64 |
| ▸ | GFER | P55789 | 1/20 | 0.64 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.64 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | OGG1 | O15527 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 2/20 | 0.55 |
| ▸ | CA2 | P00918 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9908251 | 1.00 | MPO (0.64) | MPOCYP3A4KDM5ABLMGFER | |
| Water SCHEMBL8856772 | 0.98 | MPO (0.61) | MPOCYP3A4KDM5ABLMGFER | |
| Hydrochloric Acid SCHEMBL5800195 | 0.98 | MPO (0.61) | MPOCYP3A4KDM5ABLMGFER | |
| Trifluoroacetic Acid SCHEMBL27664698 | 0.88 | PLOD2 (0.53) | MPOCYP3A4KDM5ABLMGFER | |
| SCHEMBL4249220 | 0.88 | PTPN1 (0.73) | LMNAMEN1KMT2APTPN1MITF | |
| SCHEMBL16827365 | 0.88 | CA1 (0.59) | MPOCYP3A4KDM5ABLMGFER | |
| SCHEMBL343630 | 0.87 | MPO (0.80) | MPOCYP3A4KDM5ABLMGFER | |
| SCHEMBL2678949 | 0.87 | MPO (0.80) | MPOCYP3A4KDM5ABLMGFER | |
| SCHEMBL28188923 | 0.85 | MPO (0.76) | MPOCYP3A4KDM5ABLMGFER | |
| Water SCHEMBL9038134 | 0.82 | ALDH1A1 (0.50) | MPOCYP3A4KDM5ABLMGFER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 795 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119977833-A | Synthesis and antitumor application of erianin derivative | 江苏海洋大学 | 2025-05-13 | — | — | CN | claimed |
| CN-118812539-A | 5-Aminotriazolopyrimidine derivative and preparation method thereof | 苏州大学 | 2024-10-22 | — | — | CN | claimed |
| US-20240158658-A1 | IODINE REDUCTION FOR REPRODUCIBLE AND HIGH PERFORMANCE PEROVSKITE SOLAR CELLS AND MODULES | UNITED STATES DEPARTMENT OF ENERGY | 2024-05-16 | — | — | US | claimed |
| CN-117630077-A | Based on 19 Method for detecting protein carbonylation by F nuclear magnetic resonance | 中国科学院精密测量科学与技术创新研究院 | 2024-03-01 | — | — | CN | claimed |
| CN-117402125-A | Preparation method of noo Bo Suan oxadiazole thioester compound, product and application thereof | 南京林业大学 | 2024-01-16 | — | — | CN | claimed |
| WO-2022177642-A9 | IODINE REDUCTION FOR REPRODUCIBLE AND HIGH PERFORMANCE PEROVSKITE SOLAR CELLS AND MODULES | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2022-11-03 | — | — | WO | claimed |
| CN-114685536-B | Binuclear cadmium complex with anticancer activity and preparation method and application thereof | 中山职业技术学院 | 2022-09-02 | — | — | CN | claimed |
| WO-2022177642-A2 | IODINE REDUCTION FOR REPRODUCIBLE AND HIGH PERFORMANCE PEROVSKITE SOLAR CELLS AND MODULES | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2022-08-25 | — | — | WO | claimed |
| US-11398630-B2 | Method of generating energy from a hydrazide containing anode fuel, and fuel cell | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2022-07-26 | — | — | US | claimed |
| CN-114773278-A | Quinazoline compound and application thereof in antivirus | 苏州大学 | 2022-07-22 | — | — | CN | claimed |
| CN-105669491-B | A kind of acylation method of amine | 苏州大学 | 2017-10-13 | — | — | CN | claimed |
| US-20160297732-A1 | METHOD FOR MANUFACTURING HIGH PURITY GLYCOL BASED COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-10-13 | — | — | US | claimed |
| CN-105669491-A | Acidylation method of amine | 苏州大学 | 2016-06-15 | — | — | CN | claimed |
| CN-104177459-A | 1,3,4-oxadiazole derivative containing glucosamine fragment as well as synthetic method and use of derivative | HUAIHAI INST TECHNOLOGY | 2014-12-03 | — | — | CN | claimed |
| CN-104151371-A | N-acetylglucosamine-N'-acylamino thiourea as well as synthesis method and application thereof | HUAIHAI INST TECHNOLOGY | 2014-11-19 | — | — | CN | claimed |
| CN-102690258-A | Nitrogenous heterocyclic-imide derivative and preparation method and purpose thereof | HUBEI BIOPESTICIDE ENGINEERING RES CT | 2012-09-26 | — | — | CN | claimed |
| CN-1161325-C | Diacyl hydrazide compounds as insecticide, intermediate for preparing said compounds and their preparing process | 江苏省农药研究所 | 2004-08-11 | — | — | CN | claimed |
| US-20030105140-A1 | Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof | CYTOVIA, INC. | 2003-06-05 | — | — | US | claimed |
| WO-2002102301-A2 | SUBSTITUTED INDOLE-2-CARBOXYLIC ACID BENZYLIDENE-HYDRAZIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF | CYTOVIA, INC. (US) | 2002-12-27 | — | — | WO | claimed |
| US-20020128292-A1 | Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof | CYTOVIA, INC. | 2002-09-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020128292-A1 | Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof | BAD, API5, CASP2 | MPO 2665/4885CYP3A4 1159/4885KDM5A 2065/4885 |
| US-20030105140-A1 | Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof | BAD, API5, CASP2 | MPO 2665/4885CYP3A4 1159/4885KDM5A 2065/4885 |
| US-20160297732-A1 | METHOD FOR MANUFACTURING HIGH PURITY GLYCOL BASED COMPOUND | GK, GMDS, UGCG | MPO 1470/4885CYP3A4 919/4885KDM5A 953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.